We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Naaventhan
Palaniyappan
Msznp1@nottingham.ac.uk
Prof
Guruprasad
Aithal
guru.aithal@nottingham.ac.uk
Diseases of liver
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
In chronic liver disease, scar tissue replaces normal liver tissue. We currently measure the degree of scarring in the liver by doing a liver biopsy. This involves taking a small sample of liver tissue to be assessed under a microscope. This procedure is invasive, and involves a small but significant risk.
in Nottingham, we have developed new MRI techniques that can measure liver scarring and inflammation non-invasively. In this project, we would like to study new MRI technique called MR Elastograpy. This involves giving the liver external vibration and measuring the stiffness of the liver. We believe this technique can improve the diagnosis of liver scarring and inflammation.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
1. Patients with underlying diseases which are NOT related to HCV infection, alcohol excess, non-alcoholic fatty liver disease, Hepatitis B infection, haemochromoatosis. 2. Absolute contraindications for MRI 3. Pregnant women
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Naaventhan
Palaniyappan
Msznp1@nottingham.ac.uk
Prof
Guruprasad
Aithal
guru.aithal@nottingham.ac.uk
The study is sponsored by University of Nottingham and funded by Medical Research Council (MRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 42042
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
